FDA Updates

In 2012, FDA achieved a milestone with the approval of 39 innovative drug therapies for populations in need.

Recent data were released on a long-term, open-label extension study evaluating clobazam for the adjunctive treatment of drop seizures.

New products

A survey of new Rx, new generic, and new OTC products

New Products

A survey of new Rx, new generic, and new OTC products

New products

A survey of new Rx, new generic, and new OTC products

New products

A survey of new Rx, new generic, and new OTC products

New products

A survey of new Rx, new generic, and new OTC products

What’s different in your drug stores this month? A battery-powered toothbrush for sensitive teeth and gums. A pivoting shower and bath safety grip bar. The smallest size (to date) fish oil softgels. Insoles for multiple shoe styles to help take care of various foot comfort problems. A yeast-based probiotic supplement. A “fishless†omega-3 product for vegetarians. And there are even more new over-the-counter items featured in the print edition of Drug Topics.

Brightly colored prescription warning labels applied by pharmacies fail to adequately capture the attention of older patients, suggesting that current labeling standards should be reconsidered to make them more effective, according to a study published online June 14 in PLoS ONE.

What's different in your drug stores this month? An omega-3 product for vegetarians. A no-mess scar-diminishing serum. New, more affordable toothpastes that are gentle on sensitive teeth. An omega-3 that also contains vitamin D3. A portable grip bar for shower and bath safety. An appetite suppressant that is enhanced with antioxidants. And there are even more new over-the-counter items featured in the print edition of Drug Topics.